Vital Therapies Stock Price (NASDAQ:VTL)

Add to My Stocks
$4.65 $0.05 (1.09%) VTL stock closing price Feb 21, 2017 (Closing)
Prev Close* : $4.60
Market Cap:
$147.43M
Day Low: $4.45
52 Week Low: $3.85
Open: $4.6
Volume: 50471
Day High: $4.65
52 Week High: $9.73
Dividend:
N/A

Latest Stock Market News

Latest Articles

Vital Therapies News - From Partners

VTL Stockcharts

View VTL PE ratio, PS ratio stocks charts and compare with peers.
VTL Chart
Note: Compare Vital Therapies stock price history with the index and industry peers.

VTL Industry Peers

Company Price Change (%)
Xenon Pharma (XENE)8.250.05 (0.6%)
Arbutus Biopharma (ABUS)2.70 (0%)
Cumberland Pharma (CPIX)5.590.12 (2.1%)
Chembio Diagnostics (CEMI)6.150.1 (1.65%)
Corgenix Medical (CONX)0.260.01 (3.7%)
Akers Biosciences (AKER)1.350 (0%)
Erba Diagnostics (ERBA)0.230.02 (8%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
EXACT Sciences (EXAS)22.412.5 (12.56%)
Fate Therapeutics (FATE)4.380.45 (11.45%)
Nymox Pharmaceutical (NYMX)3.540.12 (3.51%)
Myriad Genetics (MYGN)19.080.46 (2.47%)
Stemline Therapeutics (STML)6.950.15 (2.21%)
Evogene (EVGN)5.4210.11 (2.07%)
OncoMed Pharma (OMED)8.910.18 (2.06%)
Top gainers from Medical-Biomed-Genetics industry
* As of Feb 21, 2017
CompanyPriceChange (%)
Trevena (TRVN)4.272.86 (40.11%)
Momenta Pharma (MNTA)16.052.95 (15.53%)
Peregrine Pharma (PPHM)0.4790.07 (12.73%)
Cytokinetics (CYTK)10.40.85 (7.56%)
Argos Therapeutics (ARGS)4.40.3 (6.38%)
Sorrento Therapeutics (SRNE)5.250.3 (5.41%)
Immunomedics (IMMU)5.060.28 (5.24%)
Top losers from Medical-Biomed-Genetics industry
* As of Feb 21, 2017

Vital Therapies Financial Statements

income statement2015201420132012
Net Sales Or Revenues----
Net Income-52.02M-47.66M-32.71M-6.7M
Total Operating Expense52.11M50.33M31.39M9.57M
view Vital Therapies Inc income statement
balance sheet2015201420132012
Total Assets89.08M108.08M46.58M-
Total Liabilities6.75M10.51M7.76M-
Shareholders Equity82.32M97.56M38.81M-
view Vital Therapies Inc balance sheet
cash flow statement2015201420132012
Net Increase (Decrease) In Assets Liabilities-3.28M5.82M1.03M-
Net Cash From (Used By) Operating Activities-49.95M-40.82M-28.64M-
Increase (Decrease) In Prop Plant And Equipment-2.34M-1.4M-1.48M-
view Vital Therapies Inc cashflow statement

Vital Therapies Inc Stock News - Partner Headlines

Vital Therapies Stock Message Board

Vital Therapies stock lost 2.22 %, and the last close price as of 17 Feb, 2017 is 4.6 for VTL stock. Stock price or share price can be used to find the total market value of a company. Vital Therapies market cap stands at 147.43M as of 17 Feb, 2017. Investors can use valuation multiples like the P/E ratio, price to sales ratio etc. for performing Vital Therapies stock analysis.

For recognizing and analyzing the real performance of Vital Therapies stock, it is a standard practise to adjust historical stock prices to remove gaps caused by stock splits, dividends and distributions. The volume of shares traded stood at 64377 on the last trading day, as is evident from Vital Therapies stock chart, and VTL stock quote data. A dividend is a cash payment from a company's earnings and is distributed among shareholders. Vital Therapies does not pay dividends. One can observe stock price trends and check for volatility by checking Vital Therapies stock price history.